Partnering Opportunities

 

Nanopharma is actively seeking commercialization    partners to rapidly bring our technologies to market. We welcome discussions with investors and other pharmaceutical companies interested in collaborating or sub-licensing our technologies.

 

 

 

 

 

 

 

 

 

 

As a pharmaceutical development company with a strong market focus, Nanopharma seeks to develop and acquire novel antibiotics and bring them to market through a network of partnerships, thereby leveraging the strengths of multiple organizations. We are actively working with various contractors in support of our  preclinical studies and communicating with other pharmaceutical companies already interested in our pipeline. The objective of these partnerships is to synergistically combine areas of expertise and therefore facilitate and accelerate the development of our products.

 

Early in 2006, Nanopharma signed an exclusive license agreement with the University of South Florida for the commercialization of our nanoparticle-drug delivery technology.

 

For partnering opportunities, please contact Dr. Claudio Rota at:

 

crota@nanopharmatech.com